Skip to main content
SpringerLink
Log in

Comprehensive Reform of the New Drug Regulatory Process

  • Article
  • Published:
Bio/Technology Submit manuscript

Abstract

A proposal for a new agency with a new set of mandates to oversee the development of valuable new drugs and the protection of public welfare

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Mathieu, M. 1990. New Drug Development: A Regulatory Overview. Parexel International Corp., Cambridge, MA.

    Google Scholar 

  2. Peck, G.E. 1979. The food and drug laws which affect drag product design, manufacture, and distribution. In Modem Pharmaceutics, G.S. Banker and C.H. Rhodes (eds). New York: Marcel Dekker, p. 735.

    Google Scholar 

  3. Spivey, R.N.L., and A.G., Trimble, 1985. New drug applications: How long to gain approval? Clinical Pharm Therap 37: 361.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. chairman of the board and CEO of Isis Pharmaceuticals, Carlsbad, CA, 92008

    Stanley T. Crooke

Authors
  1. Stanley T. Crooke
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Crooke, S. Comprehensive Reform of the New Drug Regulatory Process. Nat Biotechnol 13, 25–29 (1995). https://doi.org/10.1038/nbt0195-25

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0195-25

  • Springer Nature America, Inc.

Search

Navigation